South London and the Maudsley NHS Foundation Trust Medicines Formulary
|
|
|
- Vincent Dennis
- 6 years ago
- Views:
Transcription
1 South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics Hypnotics Nitrazepam Temazepam Tablet 5mg Suspension 2.5mg/5ml Tablets 10mg, 20mg Oral solution 10mg/5ml Non-benzodiazepine hypnotics and other sedatives Zaleplon Capsules 5mg, 10mg Zolpidem Tablets 5mg, 10mg Zopiclone Tablets 3.75mg, 7.5mg Chloral hydrate Liquid 500mg/5ml Clomethiazole (formerly known as chlormethiazole) Promethazine hydrochloride Capsule 192mg Liquid 250mg/5ml Tablets 10mg, 25mg Liquid 5mg/5ml Melatonin Tablets MR (Circadin ) Anxiolytics Diazepam Chlordiazepoxide hydrochloride Capsules 5mg, 10mg 1
2 Lorazepam Tablets 1mg Injection 4mg/ml Oxazepam Tablets 10mg, 15mg Injection: for rapid tranquilisation only (See Trust Policy) Buspirone hydrochloride Tablets 5mg, 10mg Antipsychotics First-generation Antipsychotics Benperidol Tablets 250mcg For specialist use only Chlorpromazine hydrochloride Tablets 25mg, 50mg, 100mg Liquid 25mg/5ml Flupentixol Tablets 3mg (Depixol ) Haloperidol Levomepromazine Tablets 25mg Capsule 500mcg Tablets 500mcg, 1.5mg, 5mg, 10mg, 20mg Liquid 5mg/5ml, 10mg/5ml Injection 5ml/ml ECG monitoring is required Pericyazine Tablets 2.5mg, 10mg Liquid 10mg/5ml Perphenazine Tablets 2mg, 4mg Pimozide Tablets 4mg ECG monitoring is required Prochlorperazine Tablets 5mg, Liquid 5mg/5ml Injection 12.5mg/ml For the treatment of severe nausea and vomiting 2
3 Promazine hydrochloride Sulpiride Trifluoperazine Tablets 25mg, 50mg Liquid 25mg/5ml, 50mg/5ml Tablets 200mg, 400mg Liquid 200mg/5ml Tablets 1mg, 5mg Liquid 1mg/5ml, 5mg/5ml Zuclopenthixol Tablets 2mg, 10mg, 25mg For short-term adjunctive management of psychomotor agitation Zuclopenthixol Acetate Second-generation Antipsychotics Injection 50mg/ml (Clopixol Acuphase ) Hospital use only Amisulpride Aripiprazole Clozapine Tablets 50mg, 100mg, 200mg, 400mg Liquid 100mg/ml Tablets 5mg, 10mg, 15mg Orodispersible tablets 10mg, 15mg Liquid 1mg/ml Injection 7.5mg/ml Tablets 25mg, 100mg Liquid 100mg/5ml Orodispersible tablets and injection for hospital use only Mandatory blood monitoring requirement. All patients must be registered with the appropriate clozapine registry Lurasidone hydrochloride Tablets 18.5mg, 37mg, 74mg For hospital use only Olanzapine Tablets 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg Orodispersible tablets and injection 3
4 Orodispersible tablets 5mg, 10mg, 15mg, 20mg Injection 10mg powder for solution for injection for hospital use only Injection is available from specialist importing companies only Paliperidone Tablets MR 3mg, 6mg, 9mg Special approval required for use Quetiapine Risperidone Antipsychotic depot injections Tablets 25mg, 100mg, 150mg, 200mg, 300mg Tablets MR, 50mg, 150mg, 200mg, 300mg, 400mg Tablets 500mcg, 1mg, 2mg, 3mg, 4mg, 6mg Orodispersible tablets 500mcg, 1mg, 2mg, 3mg, 4mg Liquid 1mg/ml Orodispersible tablets for hospital use only Aripiprazole Injection 400mg Hospital use only- pending approval of shared care guidance Flupentixol decanoate Injection 20mg/mL, 100mg/mL, 200mg/ml Fluphenazine decanoate Injection25mg/mL, 100mg/mL Haloperidol decanoate Injection 50mg/mL, 100mg/mL Baseline ECG is legal requirement Olanzapine embonate Injection 210mg, 300mg, 405mg Hospital use only Requires patient observation for 3hours after the injection is given Paliperidone palmitate Injection 50mg, 75mg, 100mg, 150mg Hospital use only- pending approval of shared care guidance 4
5 Pipotiaziane palmitate Injection 50mg/mL, 100mg/2mL Restricted use only- contact pharmacy Risperidone Injection 25mg, 37.5mg, 50mg Hospital use only- pending approval of shared care guidance Zuclopenthixol decanoate Injection 200mg/mL, 500mg/mL Antimanic medicines Asenapine Sublingual tablet 5mg, 10mg Consultants to prescribe within SLAM (DTC April 2012) Carbamazepine Tablet 100mg, 200mg, 400mg MR tablet 200mg, 400mg Liquid 100mg/5mL Valproic acid as sodium valproate Valproic acid as semisodium valproate Tablet 100mg, EC tablet 200mg, 500mg MR tablet 200mg, 300mg, 500mg Liquid 200mg/5mL Lithium Carbonate Priadel tablet MR 200mg, 400mg Lthium Citrate Off license use for treatment of mania, prophylaxis of bipolar affective disorder, bipolar depression NICE EC tablet 250mg, 500mg Endorse semisodium valproate Priadel liquid 520mg/5mL (5.5mmol Li + /5mL) 4.3 Antidepressant drugs Tricyclic and related antidepressants Amitriptyline hydrochloride Tablet 10mg, 25mg, 50mg Liquid 25mg/5ml, 50mg/5mL 5
6 Clomipramine hydrochloride Dosulepin hydrochloride Capsule 10mg, 25mg, 50mg MR tablet 75mg Tablet 75mg Capsule 25mg Doxepin Capsule 25mg, 50mg Imipramine hydrochloride Tablet 10mg, 25mg Liquid 25mg/5mL Lofepramine Tablet 70mg Oral suspension 70mg/5mL Nortriptyline Tablet 10mg, 25mg Trimipramine Capsule 50mg Tablet 10mg, 25mg Capsule 50mg Mianserin hydrochloride Tablet 10mg, 30mg Trazodone hydrochloride Monoamine-oxidase inhibitors (MAOIs) Capsule 50mg, 100mg, Tablet 150mg Liquid 50mg/5mL Phenelzine Tablet 15mg Isocarboxazid Tablet 10mg Tranylcypromine Tablet 10mg, Reversible MAOIs Moclobemide Tablet 150mg 6
7 4.3.3 Selective serotonin reuptake inhibitors Citalopram Escitalopram Fluoxetine Citalopram tablet 10mg, 20mg, 40mg Oral drop 40mg/mL Tablet 5mg, 10mg, 20mg Oral drops 20mg/mL (1mg/drop) Capsule 20mg, 60mg Liquid 20mg/5mL Fluvoxamine maleate Tablet 50mg, 100mg Paroxetine Tablet 10mg, 20mg, 30mg Liquid 10mg/5mL Sertraline Tablet 50mg, 100mg Other antidepressant drugs Agomelatine Tablet 25mg For hospital use only Duloxetine Capsule 30mg, 60mg Mirtazapine Tablet 15mg, 30mg, 45mg Orodispersible tablet 15mg, 30mg, 45mg Liquid 15mg/mL Reboxetine Tablet 4mg Not recommended for use as monotherapy Venlafaxine Immediate release: tablet 37.5mg, 75mg Modified release: tablet 37.5mg, 75mg, 150mg, 225mg 7
8 capsule 75mg, 150mg Flupentixol Tablet 500microgram, 1mg 4.4 CNS stimulants and drugs used for attention and deficit hyperactivity disorder Atomoxetine Dexamfetamine sulfate Tablet 5mg Lisdexamfetamine mesilate Methylphenidate hydrochloride Capsule 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Elvanse capsule 30mg, 50mg, 70mg Hospital use only shared care guidance pending approval Immediate release: tablet 5mg, 10mg, Ritalin, Equasym Modified release: Concerta XL, Equasym XL Medikinet XL Modafinil Tablet 100mg, 200mg 4.5 Drugs used in the treatment of obesity Anti-obesity drugs acting on the gastrointestinal tract Orlistat Tablet 120mg 4.6 Drugs used in nausea and vertigo Hyoscine hydrobromide 4.8 Antiepileptic drugs Tablet chewable 300microgram Patch 1mg/ 72hours Trust off-label use, see Medicines Management Policy June 2014 Carbamazepine See under antimanic agents Oxcarbazepine Tablet 150mg, 300mg, 600mg Pregabalin Capsule 25mg, 50mg, 75mg, 100mg, 8
9 Lamotrigine Topiramate 150mg, 200mg Liquid 20mg/mL Tablet 25mg, 50mg, 100mg, 200mg Dispersible tablet 25mg, 50mg, 100mg, 200mg Tablet25mg, 50mg, 100mg, 200mg Capsules 15mg, 25mg, 50mg Sodium Valproate See under antimanic agents See above Clobazam Clonazepam Drugs used in status epilepticus Tablet 10mg, Liquid 5mg/5mL Tablet 500microgram, 2mg Liquid 500microgram/5mL, 2mg/5mL Lorazepam Tablet 1mg Injection 4mg/mL Midazolam Injection 10mg/2mL, 10mg/5mL 4.9 Drugs used in parkinsonism and related disorders Dopaminergic drugs used in Parkinson s disease Bromocriptine Tablet 1mg, 2.5mg Capsule 10mg For specialist use only (see Maudlsey Prescribing Guidelines) Cabergoline Tablet 1mg For specialist use only (see Maudlsey Prescribing Guidelines) Amantadine hydrochloride Capsule 100mg Liquid 50mg/mL For specialist use only (see Maudlsey Prescribing Guidelines) 9
10 4.9.2 Antimuscarinic drugs used in parkinsonism Orphenadrine hydrochloride Procyclidine hydrochloride Trihexyphenidyl hydrochloride (Benzhexol) Tablet 50mg Liquid 50mg/5mL Tablet 5mg Liquid 2.5mg/5mL, 5mg/5ml Injection 5mg/mL Tablet 2mg, 5mg Liquid 5mg/5mL Drugs used in essential tremor, chorea, tics and related disorders Tetrabenazine Tablet 25mg 4.10 Drugs used in substance dependence Alcohol dependence Acamprosate Tablet 333mg Disulfiram Tablet 200mg Nalmefene Tablet 18mg Initiation by Addictions consultant only Naltrexone Tablet 50mg Nicotine dependence Nicotine replacement therapy All products Varenicline Opioid dependence Tablet 500microgram, 1mg, starter pack Buprenorphine Sublingual tablet 400microgram, 10
11 Buprenorphine with naloxone Methadone hydrochloride 2mg, 8mg Sublingual tablet 2mg/500microgram, 8mg/2mg Lofexidine hydrochloride Tablet 200mcg Oral solution sugar free 1mg/1mL Oral concentrate 10mg/1mL Naloxone Injection 400mcg/1mL 4.11 Drugs used for dementia Donepezil hydrochloride Galantamine Memantine hydrochloride Rivastigmine Unlicensed and off-label used medicines Tablet 5mg, 10mg Orodispersible tablet 5mg, 10mg Tablet 4mg, 8mg, 12mg MR tablet 8mg, 12mg, 16mg, 24mg Liquid 4mg/mL Tablet 10mg, 20mg, starter pack Liquid 5mg/pump Capsule 1.5mg, 3mg, 4.5mg, 6mg, Liquid 2mg/Ml Patch 4.6mg/24hours 9.5mg/24hours Pirenzepine Tablet 50mg Hospital use only Ivabradine Tablet 5mg, 7.5mg For clozapine-related tachycardiainitiation under specialist 11
12 Selegiline Patch 6mg/24hours, 9mg/ 24hours, 12mg/24hours For use by Specialist in Affective Disorders Ketamine infusion Injection 10mg/mL Ketamine clinic (April 2014) Penfluridol Tablet 20mg Hospital use only (DTC April 2014) Melatonin Capsules various strengths Liquid 1mg/mL Midazolam Buccal liquid 10mg/1mL Unlicensed formulations Calcium Methylfolate Tablet 15mg For use by Specialist in Affective Disorders 12
Chapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE
Medicines Formulary BNF Section 4 Central Nervous System
Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam
Safe transfer of prescribing guidance
Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed
Joint Formulary for Psychotropic Medication.
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories
This document has been produced in collaboration with the Lancashire Commissioning Support Unit
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019
Chapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS
FORMULARY AND PRESCRIBING GUIDELINES 2017
FORMULARY AND PRESCRIBING GUIDELINES 2017 1 Document Control Summary Issue Date Amended Section /page Author/ Amended by 1. Sept 06 All Jane Moriba Summary of Change Removed Trust policy and guideline
Formulary Item Restrictions and/or Advice Site availability
Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine
ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
NSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.
Traffic Light Status NSFT Formulary Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present. Hospital/Specialist only Drugs for which the Trust
Introduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
NI Formulary: Chapter 4 Central Nervous system
Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,
Medications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual
West London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 3.0 (18.02.15) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
Prescriber s Guide. Stahl s Essential Psychopharmacology
Stahl s Essential Psychopharmacology Prescriber s Guide FIFTH EDITION With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this
West London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 7.0 (09.11.16) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
Psychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
Bramley Health Formulary March 2016 Review Date March 2017
Bramley Health Formulary March 2016 Review Date March 2017 This provides a formulary for use within Bramley Health. This only relates to psychiatric indications. Some of the medicines listed are also used
FORMULARY AND PRESCRIBING GUIDANCE
FORMULARY AND PRESCRIBING GUIDANCE GUIDELINE VERSION 18 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED NEXT REVIEW DATE (see specific guidelines) FORMULARY SPONSOR Executive Medical
MEDICINES FORMULARY JANUARY This version supersedes all previous versions for Medicines Formulary
EDICIES FORULARY JAUARY 2017 This version supersedes all previous versions for edicines Formulary olicy title edicines Formulary olicy HA05 reference olicy category harmacy Relevant to All staff handling
Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
Use of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
Index. Index. More information
acamprosate, alcohol dependence, 223 225, 227 228, 252 acetylcholine, role in Alzheimer s disease, 263 aerobic exercise, panic disorder, 81 agitation, schizophrenia sedation strategies, 21 agomelatine,
Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065
ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric
- how many anti-depressant pills were prescribed to patients in years 2011/12/13
NHS Wet Kent Clinical Commiioning Group Our Ref: FOI.14.WK0196 RE: FREEDOM OF INFORMATION REQUEST Thank you for your requet for information under the Freedom of Information Act 2000 received on 25 February
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following
SERVICE USER INFORMATION
SERVICE USER INFORMATION 1 Age on admission 2 Gender Male Female 3 Ethnicity White British White Irish Any other white background White and Black Caribbean White and Black African White and Asian Any other
Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit
National Mental Health Benchmarking Project Forensic Forum Special Project Seclusion Medication Audit A joint Australian, State and Territory Government Initiative October 2007 National Benchmarking Project
Guide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
Appendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
FORMULARY AND PRESCRIBING GUIDANCE
FORMULARY AND PRESCRIBING GUIDANCE GUIDELINE VERSION 13 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED August 2014 NEXT REVIEW DATE (see specific guidelines) FORMULARY SPONSOR Executive
NorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
Medicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
Medically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
FORMULARY AND PRESCRIBING GUIDELINES FOR CHILDREN AND ADOLESCENTS IN MENTAL HEALTH SERVICES
FORMULARY AND PRESCRIBING GUIDELINES FOR CHILDREN AND ADOLESCENTS IN MENTAL HEALTH SERVICES Version Control Summary Version Date Section(s) Author Comment(s)/Amendments 1 August 2008 All Sections Gbemi
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
Drugs used for the treatment of depression Selective Serotonin Reuptake Inhibitors Tricyclic and related antidepressants Others antidepressants
Central Nervous System Drugs used for the treatment of depression Anxiolytics and hypnotics Drugs used in psychosis and related disorders Drugs used in substance dependence for patients with established
IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018
MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the
INDEX. Index. in this web service Cambridge University Press
INDEX A absorption problems, 63 4 acetylcholine and extrapyramidal side effects, 59 60 memory pathways, 257 8 action potentials, ion flow, 29 30 aggression in dementia, citalopram for, 267 8 link to orbital
Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE
HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE What is HEDIS? 3 HEDIS Reference Guide for Behavioral Health 4 Behavioral Health HEDIS Measures 13 WHAT IS HEDIS? HEDIS (Healthcare Effectiveness Data and Information
NSFT Formulary Contents Error! Bookmark not defined.
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Typical Antipsychotics... 3 General Prescribing Information... 3 Atypical antipsychotics... 7 General Prescribing Information...
Guidelines on Choice and Selection of Antidepressants for the Management of Depression
Guidelines on Choice and Selection of Antidepressants for the Management of Depression 1. Introduction This guidance should be considered as part of a stepped care approach in the management of depressive
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
Formulary and Prescribing Guidelines
Formulary and Prescribing Guidelines SECTION 3: TREATMENT OF BIPOLAR AFFECTIVE DISORDER This section provides information regarding the pharmacological management of Bipolar affective disorder in secondary
Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
SHARED CARE GUIDELINE
SHARED CARE GUIDELINE Title: Prescribing and/ or Monitoring of Antipsychotics Scope: Pennine Care NHS Foundation Trust NHS Bury NHS Oldham NHS Heywood, Middleton and Rochdale NHS Stockport NHS Tameside
Guidelines on Choice and Selection of Antidepressants for the Management of Depression
Working in partnership: Hertfordshire Partnership University NHS Foundation Trust East and North Hertfordshire Clinical Commissioning Group Herts Valleys Clinical Commissioning Group Guidelines on Choice
Volume 4; Number 5 May 2010
Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated
Mental Health DNA Insight WHITE PAPER
Mental Health DNA Insight WHITE PAPER JULY 2016 Mental Health DNA Insight / White Paper Mental Health DNA Insight Pathway Genomics Mental Health DNA Insight test is aimed to help psychiatrists, neurologists,
Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY
Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY Chapter 4: CENTRAL NERVOUS SYSTEM Updated: March 2017 Drugs and driving From March 2015 a new driving offence
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible
Medicines used in Mental Health
Publication Report Medicines used in Mental Health Years 24/5 to 214/15 Publication date 13 October 215 A National Statistics Publication for Scotland Contents Introduction... 2 Hypnotics & Anxiolytics...
Therapeutic Drugs Monitoring TDM 2018 Therapeutic Drugs Monitoring Scheme Application Form
complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: TM Purchase order no.: (compulsory) TDM Distribution Schedule Samples for the
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services DRIVING AND MENTAL HEALTH CONDITIONS AND TREATMENTS General information Driving while impaired by a physical
Study Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
SAMPLE REPORT MENTAL HEALTH DNA INSIGHT LABORATORY INFO. Protected Health Information. SSRIs. TCAs. Other Antidepressants
Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. ENTAL HEALTH DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Caucasian ORDERING HEALTHCARE PROFESSIONAL Glenn Braunstein.D.
Antipsychotics. BMF 84 - Antipsychotics
Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms
SMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
4.3 Antidepressants (ADDs) BNF Section 4.3
4.3 Antidepressants (ADDs) BNF Section 4.3 The aim of this guidance is to provide prescribing guidance and highlight good practice. It is not intended to be a comprehensive practice treatment guideline.
Eligible Beneficiaries
Therapeutic Class: Behavioral Health Medications for Adults Clinical Edit Number Long Description 4110 (May change) Quantity limit edit that is applied to atypical antipsychotics for claims identified
Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
Treating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
Policy Evaluation: Low Dose Quetiapine Safety Edit
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503
NSFT Formulary Contents
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Antipsychotics... 3 General Prescribing Information... 3 Typical Antipsychotics... 5 Atypical antipsychotics... 10 General
Supplementary Online Content
Supplementary Online Content Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naïve patients in the postoperative period. JAMA Intern Med. Published
med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.
med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,
Birmingham and Solihull Mental Health NHS Foundation Trust. Formulary. March 2013
Birmingham and Solihull Mental Health NHS Foundation Trust Formulary March 2013 1 Table of contents Antipsychotics Introduction p3 1. Antipsychotics available p4 2. Mood stabilisers available p5 3. Prescribing
Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses
Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses HPFT Medicines Formulary lists the APDs that have been approved for use, however, it does not
A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
Medicines used in Mental Health
Publication Report Medicines used in Mental Health Years 26/7 to 216/17 Publication date 1 October 217 A National Statistics Publication for Scotland Contents Introduction... 2 Hypnotics & Anxiolytics...
SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS
SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the
U T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
Mixing and Matching: Layering Medications as Family Physicians
Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples
Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
* * * * * INTRODUCTION
Psychiatria Danubina, 2011; Vol. 23, No. 3, pp 320-324 Medicinska naklada - Zagreb, Croatia Conference paper AVAILABILITY OF PSYCHIATRIC MEDICATIONS TO CROATIAN HEALTHCARE USERS AND THE INFLUENCE OF AVAILABILITY
Index. E Elderly and dementia, 2 Epilepsy, 59 Escitalopram, 51, 87 Estazolam, 101 Extrapyramidal symptoms (EPS), 18
A Abilify, 143 Absolute neutrophil count (ANC), 29 Acetylcholine (Ach), 14, 15 ACTivities of daily living and cognition (ACTION) study, 167 AD Anti-inflammatory Prevention Trial (ADAPT) study, 156 Adverse
CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
Dealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
NSFT Formulary Contents
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Antipsychotics... 3 General Prescribing Information... 3 Typical Antipsychotics... 5 Atypical antipsychotics... 10 General
PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
Schedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
Medicines Guideline: High-dose antipsychotic prescribing (MG01)
Medicines Guideline: High-dose antipsychotic prescribing (MG01) Document author Assured by Review cycle Ben Browning, Locality Lead Pharmacist (Secure Services) MOG sub-group (04.05.16) Review every two
T2/T3/S62/CT012 Aide Memoire
Correct way to fill out MHA forms T2/T3/S62/CTO12 SH CP 224 T2/T3/S62/CT012 Aide Memoire Version: 2 Summary: An Aide Memoire to completing or requesting a T2/T3/S62/CT012 Keywords: Target Audience: T2,
The use of prescription psychotropic medication in
DRUGS AND PHARMACOLOGY Effect of Age on the Profile of Psychotropic Users: Results from the 2010 National Ambulatory Medical Care Survey Donovan T. Maust, MD,* David W. Oslin, MD, and Steven C. Marcus,
NSFT Formulary Contents
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Antipsychotics... 3 General Prescribing Information... 3 Typical Antipsychotics... 5 Atypical antipsychotics... 9 General